Skip to content
Bingren Liu, B.Med.

Bingren Liu, B.Med.

Radiation Oncology, Cancer

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Locations

Wilmot Cancer Institute

155 Bellwood Drive
Rochester, NY 14606

About Me

My family and I joined the war against cancer when my sister died of this disease. The science of radiation oncology combined with the art of patient care provides hope for a cure.

I have expertise in treating prostate, breast, lung and gynecologic cancers and have authored numerous journal a...
My family and I joined the war against cancer when my sister died of this disease. The science of radiation oncology combined with the art of patient care provides hope for a cure.

I have expertise in treating prostate, breast, lung and gynecologic cancers and have authored numerous journal articles related to these types of cancers, as well as the field of radiation oncology.

Conditions I Treat

- All cancers

Faculty Appointments

Associate Professor of Clinical Radiation Oncology - Department of Radiation Oncology (SMD)

Credentials

Residency & Fellowship

Residency, Radiation Oncology, Ohio State University Wexner Medical Center. 2000 - 2004

Residency, Internal Medicine, Long Island College Hospital (USA). 1999 - 2000

Education

MD | Tianjin Medical University (China). 1990

Awards

Shining Examples Award. 2009

Young Scientist Award. 1995

Publications

Journal Articles

Comparison Of Real-Time Intraoperative Ultrasound Based Dosimetry With Postoperative CT Based Dosimetry for Prostate Brachytherapy

Nag S; Liu B; et al.

Int J Radiat Oncol Biol Phys. 2008; 70(1): 311–317.

Identification of a proviral structure in human breast cancer.

Liu B, Wang Y, Melana SM, Pelisson I, Najfeld V, Holland JF, Pogo BG

Cancer research.. 2001 February 1561 (4):1754-9. Epub 1900 01 01.

Cisplatin Resistance and Regulation of DNA Repair in cAMP dependent Protein Kinase Mutants

Liu B; Jetzt A; Chin K.

Cell Growth & Differentiation. 1996; 7(8): 1105-1112.

Detection of the Expression of the Resistance Gene in Leukemia Patients by Polymerase Chain Reaction

Liu B; Young C; et al.

Chinese J Hematol. 1995; 16(2): 65-68.

Multidrug Resistance in Leukemia Cell Line K562/A02 Induced by Doxorubicin

Young C; Liu, B; et al.

Acta Pharmacol Sinica. 1995; 16(4): 333-337.

Flow Cytometric Assessment of the P-170 Expression in Leukemia Patients

Liu B; He Y; Young C.

J Exp Hematol. 1994; 2(3): 304-308.

Regulation of the multidrug resistance (MDR1) gene expression.

Chin KV, Liu B

In vivo.. 1994 8 (5):835-41. Epub 1900 01 01.

Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants.

Nguyen KT, Liu B, Ueda K, Gottesman MM, Pastan I, Chin KV

Oncology research.. 1994 6 (2):71-7. Epub 1900 01 01.

Ratings & Reviews

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.